Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Colorectal Neoplasms and MAP2K1[original query] |
---|
MAP kinase genes and colon and rectal cancer. Carcinogenesis 2012 Oct . Slattery ML, Lundgreen A, Wolff RK |
Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing. Medical oncology (Northwood, London, England) 2016 Oct 33 (10): 106. Jauhri Mayank, Bhatnagar Akanksha, Gupta Satish, Shokeen Yogender, Minhas Sachin, Aggarwal Shy |
EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Sep 39 (9): 1010428317724517. Alvarez Karin, Orellana Paulina, Villarroel Cynthia, Contreras Luis, Kawachi Hiroshi, Kobayashi Maki, Wielandt Ana Maria, De la Fuente Marjorie, Triviño Juan Carlos, Kronberg Udo, Carvallo Pilar, López-Köstner Francis |
[A Case of Metastatic Colon Cancer Dramatically Affected by Anti-EGFR Antibody Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 2016 Nov 43 (12): 1800-1802. Yagi Ryoma, Shimada Yoshifumi, Miura Kohei, Tajima Yosuke, Okamura Takuma, Nakano Masato, Ichikawa Hiroshi, Nagahashi Masayuki, Sakata Jun, Kobayashi Takashi, Kameyama Hitoshi, Wakai Toshifumi, Nogami Hitoshi, Maruyama Satoshi, Takii Yasuma |
Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents. Cancers 2019 6 11 (6): . Rachiglio Anna Maria, Lambiase Matilde, Fenizia Francesca, Roma Cristin, Cardone Claudia, Iannaccone Alessia, De Luca Antonella, Carotenuto Marianeve, Frezzetti Daniela, Martinelli Erika, Maiello Evaristo, Ciardiello Fortunato, Normanno Nico |
The extended spectrum of RAS-MAPK pathway mutations in colorectal cancer. Genes, chromosomes & cancer 2019 Oct . Costigan Danielle C, Dong F |
Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients. International journal of clinical oncology 2019 1 24 (2): 141-152. Gao Xian Hua, Yu Guan Yu, Hong Yong Gang, Lian Wei, Chouhan Hanumant, Xu Yi, Liu Lian Jie, Bai Chen Guang, Zhang W |
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers 2020 Dec 12 (12): . Knebel Franciele H, Barber Louise J, Newey Alice, Kleftogiannis Dimitrios, Woolston Andrew, Griffiths Beatrice, Fenwick Kerry, Bettoni Fabiana, Ribeiro Maurício Fernando Silva Almeida, da Fonseca Leonardo, Costa Frederico, Capareli Fernanda Cunha, Hoff Paulo M, Sabbaga Jorge, Camargo Anamaria A, Gerlinger Mar |
Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR. Scientific reports 2021 Aug 11 (1): 16333. Lim Yoojoo, Kim Sheehyun, Kang Jun-Kyu, Kim Hwang-Phill, Jang Hoon, Han Hyojun, Kim Hyoki, Kim Min Jung, Lee Kyung-Hun, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
Recurrent Somatic MAP2K1 Mutations in Papillary Thyroid Cancer and Colorectal Cancer. Frontiers in oncology 2021 5 11 670423. Bu Rong, Siraj Abdul K, Masoodi Tariq, Parvathareddy Sandeep Kumar, Iqbal Kaleem, Al-Rasheed Maha, Haqawi Wael, Diaz Mark, Victoria Ingrid G, Aldughaither Saud M, Al-Sobhi Saif S, Al-Dayel Fouad, Al-Kuraya Khawla |
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway. Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer. The oncologist 2022 5 27 (2): 104-109. Wang Chongkai, Sandhu Jaideep, Fakih Marw |
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy. JCO precision oncology 2022 5 6 e2200037. Randon Giovanni, Maddalena Giulia, Germani Marco Maria, Pircher Chiara Carlotta, Manca Paolo, Bergamo Francesca, Giordano Mirella, Sposetti Caterina, Montagna Aldo, Vetere Guglielmo, Zambelli Luca, Rasola Cosimo, Boccaccino Alessandra, Pagani Filippo, Ambrosini Margherita, Massafra Marco, Fontanini Gabriella, Milione Massimo, Fassan Matteo, Cremolini Chiara, Lonardi Sara, Pietrantonio Filip |
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 2022 11 6 e2200191. Klute Kelsey A, Rothe Michael, Garrett-Mayer Elizabeth, Mangat Pam K, Nazemzadeh Reza, Yost Kathleen J, Duvivier Herbert L, Ahn Eugene R, Cannon Timothy L, Alese Olatunji B, Krauss John C, Thota Ramya, Calfa Carmen J, Denlinger Crystal S, O'Lone Raegan, Halabi Susan, Grantham Gina N, Schilsky Richard |
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1147497. Mauri Gianluca, Patelli Giorgio, Gori Viviana, Lauricella Calogero, Mussolin Benedetta, Amatu Alessio, Bencardino Katia, Tosi Federica, Bonazzina Erica, Bonoldi Emanuela, Bardelli Alberto, Siena Salvatore, Sartore-Bianchi Andr |
Driver and targetable alterations in Chinese patients with small bowel carcinoma. Journal of cancer research and clinical oncology 2023 1 . Li Jun, Li Xiaomo, Dong Ningning, Yan Shu, Jing Chao, Ma Tonghui, Li Wei, Zhang Chenghai, Cai Yi, Deng W |
Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International journal of molecular sciences 2024 10 25 (20): . Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio, Luca Esposito, Margherita Muratore, Ilario Giovanni Rapposelli, Daniele Calistri, Elisabetta Petracci, Claudia Rengucci, Laura Capelli, Elisa Chiadini, Paola Ulivi, Alessandro Passardi, Alessandro Bitto |
- Page last reviewed:Feb 1, 2024
- Content source: